Key statistics
As of last trade, Oruka Therapeutics Inc (HQ1:STU) traded at 24.40, 45.76% above the 52 week low of 16.74 set on Feb 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 24.40 |
---|---|
High | 24.80 |
Low | 24.40 |
Bid | 24.00 |
Offer | 25.20 |
Previous close | 24.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 35.00m |
Free float | 34.05m |
P/E (TTM) | -- |
Market cap | 913.46m USD |
EPS (TTM) | -5.97 USD |
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Announcements
- Oruka Therapeutics to Present at Multiple November Investor Conferences
- Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
- Oruka Therapeutics Announces $200 Million Private Placement
- Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19
- Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
More ▼